NRC FINANCIAL STATEMENTS

National Research Corp — balance sheet, income statement and cash flow trends

NRCNational Research Corp

🇺🇸 USA · NASDAQ · Healthcare · Health Information Services

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue138.6 M $-1.9%

Gross Profit77.4 M $-7.4%

Operating Income19.6 M $-44.2%

EBITDA27.9 M $-32.4%

Net Income9 M $-62.7%

Peer Comparison· Health Information Services

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
NRC	-1.9%	55.9%	20.1%	6.5%
FONET	53.5%	39.8%	49.6%	26.0%
PME	30.3%	78.4%	78.4%	97.6%
Industry median	7.1%	63.4%	12.4%	1.5%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
NRC	-1.9%	55.9%	20.1%	6.5%
WEAV	16.8%	72.3%	-3.0%	-10.1%
TBRG	-0.5%	51.2%	9.4%	1.3%
EVH	-21.3%	14.1%	-16.7%	-26.3%
SLP	2.5%	62.0%	18.7%	-78.0%
MDRX	—	—	—	—
Industry median	7.1%	63.4%	12.4%	1.5%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity13.5 M $10%
Current Liabilities38.5 M $29%
Long-term Liabilities82.6 M $61%

Key Figures

YoY change

Total Assets134.6 M $-0.5%

Total Liabilities121.1 M $+14.7%

Total Equity13.5 M $-54.5%

Cash & ST Investments2.5 M $+1.8%

Total Debt78 M $+19.7%

Net Debt75.5 M $+20.4%

Peer Comparison· Health Information Services

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
NRC	0.52	578.2%	2.71	10.0%
FONET	2.31	2.5%	-0.21	90.9%
PME	6.22	1.1%	-1.16	72.8%
Industry median	1.83	22.0%	-0.01	64.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
NRC	0.52	578.2%	2.71	10.0%
WEAV	1.24	61.6%	2.86	40.8%
TBRG	1.78	94.3%	4.09	43.8%
EVH	1.32	248.6%	-2.61	21.1%
SLP	5.47	0.4%	-2.74	91.3%
MDRX	—	—	—	—
Industry median	1.83	22.0%	-0.01	64.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow27 M $-7.7%

Capital Expenditures9.6 M $-33.2%

Free Cash Flow17.4 M $+16.7%

Dividends Paid-11.8 M $-204.6%

Peer Comparison· Health Information Services

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
NRC	19.5%	12.6%	6.9%	298.7%
FONET	45.0%	9.6%	32.1%	173.0%
PME	56.5%	56.3%	0.2%	57.9%
Industry median	17.1%	13.0%	1.6%	165.1%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
NRC	19.5%	12.6%	6.9%	298.7%
WEAV	4.8%	3.9%	1.0%	-48.2%
TBRG	13.5%	12.1%	1.4%	1,060.2%
EVH	1.8%	0.1%	1.7%	-6.7%
SLP	30.3%	27.7%	2.5%	-38.8%
MDRX	—	—	—	-73.6%
Industry median	17.1%	13.0%	1.6%	165.1%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on NRC

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.